TY - JOUR
T1 - A systematic review of neuropsychiatric symptoms in mild cognitive impairment
AU - Camarda, Rosolino
AU - Camarda, Cecilia
AU - Monastero, Roberto
AU - Ercolani, Sara
AU - Mangialasche, Francesca
PY - 2009
Y1 - 2009
N2 - Mild cognitive impairment (MCI) is a clinical concept proposed as an intermediate state between normal aging anddementia. This condition has multiple heterogeneous sources, including clinical presentation, etiology, and prognosis. Recently,the prevalence and associated features of neuropsychiatric symptoms (NPS) in MCI have been described. We systematicallysearched the PubMed database (last accessed on August 31, 2008) for articles on NPS in MCI. Included articles used strictselection criteria, and outcome variables were extracted in duplicate; of the 27 articles included, 14 (52%) used prospectivecohorts. The global prevalence of NPS in MCI ranged from 35% to 85%. The most common behavioral symptoms weredepression, anxiety, and irritability. Hospital-based samples reported a higher global prevalence of NPS than population-basedstudies; this discrepancy probably reflected differences in demographics, study setting, MCI diagnostic criteria, and behavioralinstruments used. Prospective studies showed that NPS, particularly depression, may represent risk factors for MCI or predictorsfor the conversion of MCI to Alzheimer’s disease (AD). NPS are very prevalent in subjects with MCI, displaying a similar patternof symptoms compared to dementia and AD. Large cohort studies using standardized MCI criteria and behavioral instrumentsare required to evaluate the prognostic role of NPS in MCI
AB - Mild cognitive impairment (MCI) is a clinical concept proposed as an intermediate state between normal aging anddementia. This condition has multiple heterogeneous sources, including clinical presentation, etiology, and prognosis. Recently,the prevalence and associated features of neuropsychiatric symptoms (NPS) in MCI have been described. We systematicallysearched the PubMed database (last accessed on August 31, 2008) for articles on NPS in MCI. Included articles used strictselection criteria, and outcome variables were extracted in duplicate; of the 27 articles included, 14 (52%) used prospectivecohorts. The global prevalence of NPS in MCI ranged from 35% to 85%. The most common behavioral symptoms weredepression, anxiety, and irritability. Hospital-based samples reported a higher global prevalence of NPS than population-basedstudies; this discrepancy probably reflected differences in demographics, study setting, MCI diagnostic criteria, and behavioralinstruments used. Prospective studies showed that NPS, particularly depression, may represent risk factors for MCI or predictorsfor the conversion of MCI to Alzheimer’s disease (AD). NPS are very prevalent in subjects with MCI, displaying a similar patternof symptoms compared to dementia and AD. Large cohort studies using standardized MCI criteria and behavioral instrumentsare required to evaluate the prognostic role of NPS in MCI
KW - Alzheimer’s disease
KW - behavior
KW - dementia
KW - depression
KW - incidence
KW - mild cognitive impairment
KW - neuropsychiatric symptoms
KW - predictors
KW - prevalence
KW - risk factors
KW - Alzheimer’s disease
KW - behavior
KW - dementia
KW - depression
KW - incidence
KW - mild cognitive impairment
KW - neuropsychiatric symptoms
KW - predictors
KW - prevalence
KW - risk factors
UR - http://hdl.handle.net/10447/63124
M3 - Article
SN - 1387-2877
VL - 8
SP - 11
EP - 30
JO - Journal of Alzheimer's Disease
JF - Journal of Alzheimer's Disease
ER -